RankAlpha logo
Back to Rankings

PRME

Prime MedicineD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
PRME vs peer average
34/100
PRME vs. peer average (D vs. C)
Grade spread
A 3 · C 1 · D 2 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

ALT is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $546.47M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerALTAltimmune
PRME
Prime Medicine
ALT
Altimmune
Grade
D
F
Momentum
54
15
Value
41
41
Sentiment
-
-
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs ALT

PRME / ALT
Grade Position
Below peers
PRME vs. peer average (D vs. C)
34/100
Momentum
54
PRME
Value
41
PRME
Sentiment
-
-

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs PRME
1
ALT
Altimmune Inc Common
F
20/100
+1
2
MYGN
Myriad Genetics Inc Common
A
100/100
-3
3
MLAB
Mesa Laboratories Inc Common
D
40/100
Even
4
RGNX
REGENXBIO Inc Common
A
100/100
-3
5
NVCT
Nuvectis Pharma Inc Common
D
40/100
Even
ALT is the first peer returned for this comparison set.